Contrary to our expectation, the expression of plasma LeXis was significantly upregulated in patients with NASH compared with that in those without (4.6 (4.0–6.6) vs. 8.2 (5.0–14.9), p = 0.025; Figure 4). The gene discussed is CT70; the disease is metabolic dysfunction-associated steatohepatitis.